Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Antibacterials

A sweet vaccine

Nature Chemistry volume 8, pages 201–202 (2016)Cite this article

Subjects

A Correction to this article was published on 21 October 2016

This article has been updated

Vaccination with a synthetic glycoconjugate, in combination with the administration of an inhibitor that blocks capsular polysaccharide synthesis in bacteria, could offer an alternative route to combat bacterial infections.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Inhibition of capsular polysaccharide (CPS) export enables recognition and killing of bacteria.

Change history

  • 18 October 2016

    In the News & Views 'A sweet vaccine' (Nature Chemistry 8, 201–202; 2016), an in-house error meant that Ben Davis was twice referred to as Ben Davies. This error has been corrected after print 18 October 2016

References

  1. Liu, Y. et al. Lancet Infect. Dis. 16, 161–168 (2016).

    Article  Google Scholar 

  2. Kong, L. et al. Nature Chem. 8, 242–249 (2016).

    Article  CAS  Google Scholar 

  3. Fu, Y., Baumann, M., Kosma, P., Brade, L. & Brade, H. Infect. Immun. 60, 1314–1321 (1992).

    CAS  PubMed  PubMed Central  Google Scholar 

  4. Borrelli, S., Diab, A., Lindberg, A. & Svanborg, C. Microb. Pathogenesis 28, 1–8 (2000).

    Article  CAS  Google Scholar 

  5. Plested, J. S. et al. J. Infect. Dis. 187, 1223–1234 (2003).

    Article  CAS  Google Scholar 

  6. Gidney, M. A. et al. Infect. Immun. 72, 559–569 (2004).

    Article  CAS  Google Scholar 

  7. Müller-Loennies, S., Brade, L. & Brade, H. Int. J. Med. Microbiol. 297, 321–340 (2007).

    Article  Google Scholar 

  8. Jäkel, A. et al. Vaccine 26, 6655–6663 (2008).

    Article  Google Scholar 

  9. Parker, M. J. et al. Glycobiology 24, 442–449 (2014).

    Article  CAS  Google Scholar 

  10. Müller-Loennies, S. et al. J. Endotoxin. Res. 8, 295–305 (2002).

    Article  Google Scholar 

  11. Boltje, T. J. et al. J. Am. Chem. Soc. 134, 14255–14262 (2012).

    Article  CAS  Google Scholar 

  12. Yang, Y., Oishi, S., Martin, C. E. & Seeberger, P. H. J. Am. Chem. Soc. 135, 6262–6271 (2013).

    Article  CAS  Google Scholar 

  13. Reinhardt, A. et al. Chem. Biol. 22, 38–49 (2015).

    Article  CAS  Google Scholar 

  14. Dong, C. et al. Nature 444, 226–229 (2006).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. David Bundle is in the Department of Chemistry, University of Alberta, Edmonton, Alberta T6G 2G2, Canada,

    David Bundle

Authors
  1. David Bundle
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to David Bundle.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bundle, D. A sweet vaccine. Nature Chem 8, 201–202 (2016). https://doi.org/10.1038/nchem.2468

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nchem.2468

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing